IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2006;47:3395-3399.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0100
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ota, T.
Right arrow Articles by Araie, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ota, T.
Right arrow Articles by Araie, M.

The Effects of Prostaglandin Analogues on Prostanoid EP1, EP2, and EP3 Receptor-Deficient Mice

Takashi Ota,1 Makoto Aihara,1 Tadashiro Saeki,1 Shuh Narumiya,2 and Makoto Araie1

1From the Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan; and the 2Department of Pharmacology, Kyoto University Faculty of Medicine, Kyoto, Japan.

PURPOSE. To determine the role of prostanoid EP receptors in the intraocular pressure (IOP)–lowering effect of prostaglandin analogues in EP receptor-deficient mice.

METHODS. Animals were bred and acclimatized in a 12-hour light-dark cycle. The diurnal IOP variation was measured by a microneedle method in EP1, EP2, and EP3 receptor-deficient mice (EP1KO, EP2KO and EP3KO) and in their wild-type (WT) background strain. IOP was measured in each mouse at night 3 hours after application of latanoprost, travoprost (0.004%), bimatoprost (0.03%), or unoprostone (0.12%). In WT and EP3KO mice, the effects of preapplication of diclofenac Na on drug-induced IOP reduction were examined.

RESULTS. Baseline IOPs were the same for all strains. Higher baseline IOPs were observed at night. Maximum IOP reduction occurred in WT mice 3 hours after latanoprost application during the day and night. Three hours after instillation at night, each of the four drugs lowered IOP significantly in WT, EP1KO, and EP2KO mice, whereas EP3KO a significantly lesser effect was induced by latanoprost, travoprost, and bimatoprost. Preapplication of diclofenac Na significantly attenuated drug-induced IOP reduction in WT but not in EP3KO mice.

CONCLUSIONS. Deficiency of EP receptors had no effect on physiological IOP. EP1 and EP2 receptors are not involved in prostaglandin analogue-induced IOP reduction, whereas EP3 receptors may play a role.




This article has been cited by other articles:


Home page
 IOVSHome page
R.-F. Wang, D. J. Gagliuso, T. W. Mittag, and S. M. Podos
Effect of 15-Keto Latanoprost on Intraocular Pressure and Aqueous Humor Dynamics in Monkey Eyes
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4143 - 4147.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
T. Ota, M. Aihara, T. Saeki, S. Narumiya, and M. Araie
The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice
Br. J. Ophthalmol., May 1, 2007; 91(5): 673 - 676.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology